We assessed Plasmodium falciparum drug resistance markers in parasites collected in 2012, 2013, and 2015 at 3 sites in Uganda. The prevalence and frequency of parasites with mutations in putative transporters previously associated with resistance to aminoquinolines, but increased sensitivity to lumefantrine (pfcrt 76T; pfmdr1 86Y and 1246Y), decreased markedly at all sites. Antifolate resistance mutations were common, with apparent emergence of mutations (pfdhfr 164L; pfdhps 581G) associated with high-level resistance. K13 mutations linked to artemisinin resistance were uncommon and did not increase over time. Changing malaria treatment practices have been accompanied by profound changes in markers of resistance
Abstract. In January 2007, Tanzania replaced sulfadoxine-pyrimethamine (SP) with artemether-lumefant...
Summary: Background: Treatment and control of malaria depends on artemisinin-based combination ther...
BackgroundIn Uganda, artemether-lumefantrine is recommended for malaria treatment and sulfadoxine-py...
: We assessed Plasmodium falciparum drug resistance markers in parasites collected in 2012, 2013, an...
We assessed Plasmodium falciparum drug resistance markers in parasites collected in 2012, 2013, and ...
The potential spread of antimalarial drug resistance to Africa, in particular for artemisinins and k...
Standard therapy for malaria in Uganda changed from chloroquine to chloroquine + sulfadoxine-pyrimet...
Standard therapy for malaria in Uganda changed from chloroquine to chloroquine + sulfadoxine-pyrimet...
BACKGROUND: Partial resistance of Plasmodium falciparum to the artemisinin component of artemisinin-...
BACKGROUND: In Uganda, artemether-lumefantrine is recommended for malaria treatment and sulfadoxine-...
Background: In Tanzania, drug-resistant malaria parasites are an increasing public health concern. B...
Background: The emergence of drug resistance is a major problem in malaria control. Combination of m...
Artemisinin partial resistance may facilitate selection of Plasmodium falciparum resistant to combin...
Background Drug resistance is one of the main reasons of anti-malarial treatment failures and imped...
Artemisinin resistance (AR) emerged in South East Asia 13 years ago and the identification of the re...
Abstract. In January 2007, Tanzania replaced sulfadoxine-pyrimethamine (SP) with artemether-lumefant...
Summary: Background: Treatment and control of malaria depends on artemisinin-based combination ther...
BackgroundIn Uganda, artemether-lumefantrine is recommended for malaria treatment and sulfadoxine-py...
: We assessed Plasmodium falciparum drug resistance markers in parasites collected in 2012, 2013, an...
We assessed Plasmodium falciparum drug resistance markers in parasites collected in 2012, 2013, and ...
The potential spread of antimalarial drug resistance to Africa, in particular for artemisinins and k...
Standard therapy for malaria in Uganda changed from chloroquine to chloroquine + sulfadoxine-pyrimet...
Standard therapy for malaria in Uganda changed from chloroquine to chloroquine + sulfadoxine-pyrimet...
BACKGROUND: Partial resistance of Plasmodium falciparum to the artemisinin component of artemisinin-...
BACKGROUND: In Uganda, artemether-lumefantrine is recommended for malaria treatment and sulfadoxine-...
Background: In Tanzania, drug-resistant malaria parasites are an increasing public health concern. B...
Background: The emergence of drug resistance is a major problem in malaria control. Combination of m...
Artemisinin partial resistance may facilitate selection of Plasmodium falciparum resistant to combin...
Background Drug resistance is one of the main reasons of anti-malarial treatment failures and imped...
Artemisinin resistance (AR) emerged in South East Asia 13 years ago and the identification of the re...
Abstract. In January 2007, Tanzania replaced sulfadoxine-pyrimethamine (SP) with artemether-lumefant...
Summary: Background: Treatment and control of malaria depends on artemisinin-based combination ther...
BackgroundIn Uganda, artemether-lumefantrine is recommended for malaria treatment and sulfadoxine-py...